Study design:
	The researchers randomly assigned 165 patients to two groups:  in one group, 83 patients were continued on antipsychotic drug therapy;  in the second group, 82 patients were switched to placebo (inert pill).
	The investigators carefully monitored the patients for compliance with the new treatments.
	Primary outcome:           1-year mortality